|
Volumn 16, Issue , 2016, Pages 115-140
|
Heart
a,b b,c b d,e d,e b,f b,f,g b,g |
Author keywords
End stage heart failure; heart transplant; transplant outcomes; ventricular assist device
|
Indexed keywords
INTERLEUKIN 2;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
MYCOPHENOLIC ACID;
TACROLIMUS;
ARTICLE;
CARDIOMYOPATHY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CEREBROVASCULAR DISEASE;
CORONARY ARTERY DISEASE;
FEMALE;
FIRST AID;
GRAFT FAILURE;
GRAFT RECIPIENT;
HEART TRANSPLANTATION;
HOSPITAL ADMISSION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INTRAAORTIC BALLOON PUMP;
MALE;
ORGAN DONOR;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RACE DIFFERENCE;
RIGHT VENTRICULAR ASSIST DEVICE;
SEX DIFFERENCE;
TOTAL ARTIFICIAL HEART;
ADOLESCENT;
ADULT;
AGED;
CHILD;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART FAILURE;
KAPLAN MEIER METHOD;
MIDDLE AGED;
OUTCOME ASSESSMENT;
PRESCHOOL CHILD;
PROCEDURES;
STATISTICS AND NUMERICAL DATA;
TIME FACTOR;
TRANSPLANTATION;
TREATMENT OUTCOME;
UNITED STATES;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART FAILURE;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSION;
INCIDENCE;
KAPLAN-MEIER ESTIMATE;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
TIME FACTORS;
TISSUE AND ORGAN PROCUREMENT;
TREATMENT OUTCOME;
UNITED STATES;
WAITING LISTS;
YOUNG ADULT;
|
EID: 84954095578
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/ajt.13670 Document Type: Article |
Times cited : (29)
|
References (0)
|